undefined undefined
NaN.000
NaN.00%
Nyxoah press release (NASDAQ:NYXH): Q1 GAAP EPS of €0.415. Revenue of €1.2M (vs. €441,000 in Q1/2023). More on Nyxoah Nyxoah S.A. (NYXH) Q4 2023 Earnings Call Transcript Nyxoah says Genio pivotal stud...
05-15 22:27
Gainers: SINTX Technologies (SINT) +186%. Faraday Future Intelligent Electric (FFIE) +82%. Edible Garden AG (EDBL) +82% after Q1 earnings release. AERWINS Technologies (AWIN) +33%. Greenwave Technolog...
05-15 21:25
Nyxoah Sa (BE:NYXH) has released an update. Nyxoah SA, a medical tech firm spec...
05-15 05:27
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
04-16 19:00
Gainers: Rallybio (RLYB) +84%. Eliem Therapeutics (ELYM) +59%. Alpine Immune Sciences (ALPN) +36%. Candel Therapeutics (CADL) +28%. Enliven Therapeutics (ELVN) +29%. Losers: Aptevo Therapeutics (APVO)...
04-11 22:04
Olivier Taelman, Nyxoah's Chief Executive Officer, said, "We are finalizing the fourth and final module submission in the PMA application and I look forward to launching Genio in the U.S, pending FDA
03-20 04:06
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Monday.
03-18 22:13
12月31日,Nyxoah Sa(NYXH.US)公布财报,公告显示公司2023财年净利润为-46.72百万美元,同比减少42.35%;其中营业收入为4.70百...
03-09 00:26
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
03-05 18:00
Nyxoah (NASDAQ:NYXH) is set to give its latest quarterly earnings report on Tue...
03-05 02:02